Notable movers of interest
The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).
Large Cap Gainers
• MHK (182.69 +5.8%): Beat Q4 consensus EPS estimates by $0.06, reported revs in-line; guided Q1 EPS in-line.
• NEM (26.25 +7.3%): Reported Q4 (Dec) earnings of $0.17 per share, excluding non-recurring items, $0.06 better than the Capital IQ Consensus Estimate of $0.11; revenues fell 7.0% year/year to $2.02 bln vs the $1.81 bln consensus.
• INTU (96.07 +5.44%): Beat Q2 consensus EPS estimates by $0.07, beat on revs; guided Q3 (tax quarter) below consensus, Q4 above consensus; Price Target raised to $100 at Oppenheimer.
Large Cap Losers
• DISCA (30 -3.54%): Reported Q4 (Dec) earnings of $0.43 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus Estimate of $0.42; revenues rose 9.0% year/year to $1.68 bln vs the $1.7 bln consensus.
• EOG (90.67 -3.34%): Downgraded to neutral at UBS, Macquarie; Downgraded to Underweight at Capital One.
• RY (60.53 -2.04%): Downgraded to Underperform from Mkt Perform at Keefe Bruyette.
Mid Cap Gainers
• TEP (50.87 +5.99%): Reported Q4 (Dec) earnings of $0.45 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.42; revenues rose 26.2% year/year to $109.5 mln vs the $118.56 mln consensus; co expects its current annualized distribution rate of $1.94 to increase by approximately 20 percent for the calendar year 2015.
• B (39 +4.84%): Beat Q4 consensus EPS estimates by $0.01, reported revs in-line; guided FY15 in-line.
• SLXP (156.88 +4.07%): Further reports out that Valeant (VRX) is a near a deal to acquire Salix, and such a deal could be announced next week.
Mid Cap Losers
• IRM (36.6 -5.74%): Missed Q4 consensus EPS estimates by $0.03, missed on revs; lowered FY15 guidance.
• OIS (40.94 -4.99%): Downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $43 from $56.
• AVP (8.4 -3.84%): Price target lowered to $8 from $9 at RBC Capital Mkts.
AI
